Characterization of microbial and host requirements for colonic biofilm assembly and biofilm-mediated colon tumorigenesis
结肠生物膜组装和生物膜介导的结肠肿瘤发生的微生物和宿主需求的表征
基本信息
- 批准号:10249484
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2023-08-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAgeAnimal ModelAntibodiesApcMin/+ miceApoptosisBacteriaBacterial ModelBacteroidetesBiological Response ModifiersBiologyCancer EtiologyCellsCessation of lifeClinical ResearchColonColonoscopyColorectal CancerCommunitiesDataData SetDevelopmentDistalE-CadherinEpidemiologyEpithelialEpithelial CellsEpitheliumFamilial colorectal cancerFlow CytometryGerm-FreeGrantHealthHistologicHumanImageImmuneImmune responseImmune signalingIn Situ Nick-End LabelingIndividualInterleukin-17Interleukin-6Intestinal NeoplasmsKnock-outKnockout MiceLaboratoriesLeadLeftMalignant NeoplasmsMass Spectrum AnalysisMediatingMediator of activation proteinMetabolicMethodsMicrobeMicrobial BiofilmsModificationMucous MembraneMusNormal tissue morphologyPatientsPhenotypePlayPolyaminesProductionQuantitative Reverse Transcriptase PCRRoleSamplingSideSignal PathwayStainsSuggestionTestingTherapeuticTimeTissuesVirulence Factorsbasecarcinogenesiscolon cancer patientscolon hepatic flexurecolon tumorigenesiscolorectal cancer preventioncolorectal cancer riskcytokineexperimental studyglobal healthgut microbiomeinhibitor/antagonistmetabolomicsmicrobialmicrobial hostmicrobiomemouse modelmucosal biofilmsnoveloutcome forecastprospectiveresponsescreeningsingle-cell RNA sequencingtherapeutic biomarkertherapeutic targettooltumortumor progressiontumorigenesistumorigenic
项目摘要
Sporadic colorectal cancer (CRC) remains a global health burden as one of the leading causes of cancer
and cancer-related deaths, and, strikingly, is also emerging as an acute health crisis in younger patients in
the US under the age of 50. These data suggest that novel efforts to identify contributors to the changing
landscape of CRC are urgently needed. In this R00 proposal, we seek to dissect the assembly and
tumorigenic mechanisms behind invasive, polymicrobial colonic biofilms, which were previously
established in the Sears laboratory to be a nearly universal feature of CRC tumors proximal to the hepatic
flexure. Biofilms were also identified on a subset (10-15%) of healthy patients without CRC, in whom
biofilms were associated with early, procarcinogenic changes, positing a role for bacterial biofilms in CRC
development. These biofilms were also associated with elevations in polyamine metabolites in mass
spectrometry-based analyses and induced a strong Interleukin-17 (IL-17) response in the mice by one
week, a cytokine signature associated with a worse prognosis in human CRC. Tissue slurries made from
human biofilms re-assembled into biofilms in the distal mouse colon; some - but not all – of these slurries
were directly tumorigenic in germ-free ApcMin/+ mice by 10-15 weeks. Extensive culturing of one
tumorigenic slurry following inoculation into mice revealed 35 bacterial isolates that, when re-inoculated
into additional mice, recapitulated the tumorigenesis of the original patient tumor slurry. Our specific aims
seek to build on these preliminary studies. Specific Aim (SA) 1 will identify the critical bacterial species
within the 35 isolate mixture that are responsible for biofilm formation and tumorigenesis. SA2 will test the
hypothesis that IL-17 and other immune parameters are critical mediators of biofilm formation and
biofilm-mediated tumorigenesis utilizing a combination of single-cell RNA sequencing, flow cytometry, and
qRT-PCR. Therapeutic modulation with an IL-17 antibody or knockout mice will be used to confirm the
requirement of IL-17 in biofilm formation and biofilm-mediated tumorigenesis. SA3 will utilize advanced
mass spectrometry methods to determine metabolites associated with biofilms in both patient and mouse
tissues and the localization of these metabolites in select samples. The experiments in this proposal will
provide valuable information regarding the host and microbial requirements for biofilm formation and
biofilm-mediated tumorigenesis that may lead to potential therapeutic targets or biomarkers for biofilms.
散发性结直肠癌(CRC)作为癌症的主要原因之一,仍然是全球健康负担
和癌症相关的死亡,而且,引人注目的是,也正在成为一个严重的健康危机,在年轻的病人,
美国50岁以下。这些数据表明,新的努力,以确定贡献者的变化,
目前迫切需要建立一个区域中心景观。在这个R 00提案中,我们试图剖析大会,
肿瘤发生机制背后的侵入性,多微生物结肠生物膜,这是以前
在Sears实验室中被确定为接近肝脏的CRC肿瘤的几乎普遍特征,
弯曲生物膜也在一个亚组(10-15%)的无CRC的健康患者中鉴定,其中
生物膜与早期的前致癌变化相关,这表明细菌生物膜在结直肠癌中发挥作用
发展这些生物膜也与多胺代谢物的质量升高有关。
基于光谱的分析,并通过一种方法在小鼠中诱导强烈的白细胞介素-17(IL-17)应答。
周,与人CRC预后不良相关的细胞因子特征。组织浆,由
人类生物膜在远端小鼠结肠中重新组装成生物膜;这些浆液中的一些(但不是全部)
在无菌ApcMin/+小鼠中直接致瘤10-15周。广泛培养一个
接种到小鼠体内后的致瘤浆液显示35种细菌分离株,当再次接种时,
在另外的小鼠中,重现了原始患者肿瘤浆液的肿瘤发生。我们的具体目标
在这些初步研究的基础上继续努力。特定目标(SA)1将确定关键细菌菌种
在35个分离物混合物中,它们负责生物膜形成和肿瘤发生。SA 2将测试
假设IL-17和其他免疫参数是生物膜形成的关键介质,
生物膜介导的肿瘤发生,利用单细胞RNA测序,流式细胞术,
qRT-PCR。使用IL-17抗体或敲除小鼠的治疗性调节将用于确认IL-17抗体在小鼠体内的表达。
IL-17在生物膜形成和生物膜介导的肿瘤发生中的需求。SA 3将利用先进的
测定患者和小鼠中与生物膜相关的代谢物的质谱法
组织和这些代谢物在选定样品中的定位。该提案中的实验将
提供关于生物膜形成的宿主和微生物要求的有价值的信息,
生物膜介导的肿瘤发生,可能导致潜在的治疗靶点或生物膜的生物标志物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julia L Drewes其他文献
Julia L Drewes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Julia L Drewes', 18)}}的其他基金
Characterization of microbial and host requirements for colonic biofilm assembly and biofilm-mediated colon tumorigenesis
结肠生物膜组装和生物膜介导的结肠肿瘤发生的微生物和宿主需求的表征
- 批准号:
10252076 - 财政年份:2020
- 资助金额:
$ 24.9万 - 项目类别:
Characterization of microbial and host requirements for colonic biofilm assembly and biofilm-mediated colon tumorigenesis
结肠生物膜组装和生物膜介导的结肠肿瘤发生的微生物和宿主需求的表征
- 批准号:
10456150 - 财政年份:2020
- 资助金额:
$ 24.9万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Research Grant